micro-community-banner
  • Saved
Immunoglobulin National Society 2024: 13th Annual Conference

The Immunoglobulin National Society (IgNS) 13th National Conference took place at the Gaylord National Resort & Convention Center in Washington, D.C., from Oct. 17 through 20, 2024. More than 1,200 nurses, pharmacists, physicians, and business leaders attended the four-day meeting.

The meeting featured the latest news and views on the treatment of myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, common variable immunodeficiency, primary immune thrombocytopenia, dermatomyositis, polymyositis, juvenile dermatomyositis, and other conditions.

Above, please find our postconference wrap-up report.

  • Saved
American Association of Neuromuscular & Electrodiagnostic Medicine Annual Meeting

The 2024 annual meeting of the American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) took place at the Savannah Convention Center and Westin Savannah Harbor in Georgia. Speakers at the four-day meeting covered the latest advances in neuromuscular and musculoskeletal disorders and electrodiagnostic medicine. The meeting also included sessions by the Myasthenia Gravis Foundation of America, Peripheral Nerve Society, and Dysautonomia International.

Above, please find our postconference wrap-up report, which takes a closer look at the myasthenia gravis data presented during the meeting.

  • Saved
Thymus Surgery Prospectives and Perspectives in Myasthenia Gravis - PubMed

Thymus Surgery Prospectives and Perspectives in Myasthenia Gravis - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/38540983/

The thymus is a lymphoid organ involved in the differentiation of T cells, and has a central role in the physiopathogenesis of Myasthenia Gravis (MG). This connection is proved by...

The paper reviews thymectomy's role in Myasthenia Gravis treatment, highlighting its impact on T cell differentiation, neuromuscular junctions, and hospital stay reductions through minimally invasive surgical techniques.

  • Saved
Myasthenia Gravis with Toxic Goiter: Challenges with Management in a Low-Resource Setting in Africa; Review of Literature and Case Report - PubMed

Myasthenia Gravis with Toxic Goiter: Challenges with Management in a Low-Resource Setting in Africa; Review of Literature and Case Report - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/38317049/

Myasthenia gravis (MG) is an antibody-mediated autoimmune disease with the cardinal feature being exertional voluntary skeletal muscle weakness and fatigability. It can be an isolated finding or in association with...

A 24-year-old with myasthenia gravis and toxic goiter underwent thymectomy and subtotal thyroidectomy, achieving satisfactory outcomes. This case highlights the coexistence of MG with thymoma and goiter.

  • Saved
American Association of Neuromuscular & Electrodiagnostic Medicine Annual Meeting

Taking place at the Savannah Convention Center and Westin Savannah Harbor in Georgia, the 2024 annual meeting of the American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) spans four days and features the latest advances in neuromuscular and musculoskeletal disorders and electrodiagnostic medicine, including emerging gene therapies and new technologies. The meeting also includes sessions by the Myasthenia Gravis Foundation of America, Peripheral Nerve Society, and Dysautonomia International.

Above, we summarize some presentations that caught our eye at the conference. We will follow this up with a postconference wrap-up report. Stay tuned.